Knott David M JR
$184M 13F equity value
87 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Knott David M JR covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| GOOG | Alphabet Inc-Cl C | 91,420 | $32M | 17.6% |
| APO | Apollo Global Management, Inc. | 225,000 | $27M | 14.5% |
| SNDX | Syndax Pharmaceutical, Inc. | 437,245 | $10M | 5.2% |
| XERS | Xeris Biopharma Holdings, Inc. | 1,060,000 | $8M | 4.6% |
| TVTX | Travere Therapeutics, Inc. | 147,282 | $8M | 4.6% |
| PTGX | Protagonist Therapeutics, Inc | 63,000 | $8M | 4.2% |
| BBIO | Bridgebio Pharma, Inc. | 92,850 | $7M | 3.8% |
| IOVA | Iovance Biotherapeutics, Inc. | 1,600,000 | $7M | 3.6% |
| ALKS | Alkermes PLC | 121,759 | $6M | 3.5% |
| JPM | JPMorgan Chase & Co. | 18,098 | $6M | 3.2% |
Track Knott David M JR's 13F portfolio: $184M in reported holdings, 87 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}